1. There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse...
1. In this randomized controlled trial, algorithmic identification based on electronic health records (EHRs) and practice facilitators did not reduce...
1. In a cohort of men with prostate cancer, disease progression was lower in men who had a higher intake...
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo group, with...
1. Therapeutic response at days 10-13 was greater in the gepotidacin group compared to the nitrofurantoin group across both trials....
1. In this randomized controlled trial, among hospitalized adults with a complicated urinary tract infection (UTI), cefepime-taniborbactam was superior to...
1. In this randomized controlled trial, topical testosterone was not superior to placebo in reducing the risk of fractures in...
![Galangin may sensitize apoptosis-resistant renal carcinoma cells [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2016/01/Papillary_renal_cell_carcinoma_-_very_high_mag-350x250.jpg)
1. This prospective study found that the Systematic Inflammatory Response Index (SIRI) and Systemic Immune-Inflammation Index (SII), as well as...
1. In a population of men with hypogonadism and PSA concentrations less than 3 ng/mL, patients randomized to receive testosterone...
1. This randomised control trial demonstrated that a standardised and manualised intervention in primary care showed a sustained reduction in...
